Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis

Tissue Engineering - Part A

Volumn 17, Issue 9-10, 2011, Pages 1181-1189

  Tengood, Jillian E ^a,b   Ridenour, Ryan ^c   Brodsky, Ross ^d   Russell, Alan J ^b,d,e   Little, Steven R ^a,b,d  

^a University of Pittsburgh   (United States)

^b MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^c Pittsburgh Tissue Engineering Initiative Inc   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELL CULTURE; ENDOTHELIAL CELLS; FIBROBLASTS; MICROCIRCULATION; PLATELETS;

ANGIOGENESIS; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; COLOCALIZATION; PLATELET-DERIVED GROWTH FACTORS; RED BLOOD CELL; SEQUENTIAL DELIVERY; TEMPORAL SEPARATION; VASCULATURE;

PEPTIDES;

FIBROBLAST GROWTH FACTOR 2; PLATELET DERIVED GROWTH FACTOR;

ANGIOGENESIS; ANIMAL; ARTICLE; CELL MOTION; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; METABOLISM; MOUSE; PERICYTE; PHYSIOLOGY;

ANIMALS; CELL MOVEMENT; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PERICYTES; PLATELET-DERIVED GROWTH FACTOR;

EID: 79955034765     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0551     Document Type: Article

References (59)

1. Grakoui, A., Bromley, S.K., Sumen, C., Davis, M.M., Shaw, A.S., Allen, P.M., and Dustin, M.L. The immunological synapse: a molecular machine controlling T cell activation. Science 285, 221, 1999.
2. Steinman, R.M., Hawiger, D., and Nussenzweig, M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21, 685, 2003.
3. Hamaguchi, K., Utsunomiya, N., Takaki, R., Yoshimatsu, H., and Sakata, T. Cellular interaction between mouse pancreatic alpha-cell and beta-cell lines: possible contact-dependent inhibition of insulin secretion. Exp Biol Med (Maywood) 228, 1227, 2003.
4. Bartness, T.J., Shrestha, Y.B., Vaughan, C.H., Schwartz, G.J., and Song, C.K. Sensory and sympathetic nervous system control of white adipose tissue lipolysis. Mol Cell Endocrinol 318, 34, 2010.
5. Martin, T.J., and Sims, N.A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11, 76, 2005.
6. Boüs, D., Kusumanto, Y., Meijer, C., Mulder, N.H., and Hospers, G.A. A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 53, 89, 2006.
7. Bauer, S.M., Bauer, R.J., Liu, Z.J., Chen, H., Goldstein, L., and Velazquez, O.C. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels. J Vasc Surg 41, 699, 2005.
8. Przybylski, M. A review of the current research on the role of bFGF and VEGF in angiogenesis. J Wound Care 18, 516, 2009.
9. Raza, A., Franklin, M.J., and Dudek, A.Z. Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol 85, 593, 2010.
10. Kawanabe, T., Kawakami, T., Yatomi, Y., Shimada, S., and Soma, Y. Sphingosine 1-phosphate accelerates wound healing in diabetic mice. J Dermatol Sci 48, 53, 2007.
11. Tabata, Y.,Miyao,M., Ozeki, M., and Ikada, Y. Controlled release of vascular endothelial growth factor by use of collagen hydrogels. J Biomater Sci Polymer Ed 11, 915, 2000.
12. Schweigerer, L., Neufeld, G., Friedman, J., Abraham, J.A., Fiddes, J.C., and Gospodarowicz, D. Basic fibroblast growth factor: production and growth stimulation in cultured adrenal cortex cells. Endocrinology 120, 796, 1987.
13. Simons, M., Bonow, R.O., Chronos, N.A., Cohen, D.J., Giordano, F.J., Hammond, H.K., Laham, R.J., Li, W., Pike, M., Sellke, F.W., Stegmann, T.J., Udelson, J.E., and Rosengart, T.K. Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation 102, E73, 2000.
14. De Marchis, F., Ribatti, D., Giampietri, C., Lentini, A., Faraone, D., Scoccianti, M., Capogrossi, M.C., and Facchiano, A. Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor. Blood 99, 2045, 2002.
15. Facchiano, A., De Marchis, F., Turchetti, E., Facchiano, F., Guglielmi, M., Denaro, A., Palumbo, R., Scoccianti, M., and Capogrossi, M.C. The chemotactic and mitogenic effects of platelet-derived growth factor-BB on rat aorta smooth muscle cells are inhibited by basic fibroblast growth factor. J Cell Sci 113 (Pt 16), 2855, 2000.
16. Hammond, P.T. Form and function in multilayer assembly: new applications at the nanoscale. Adv Mater 16, 1271, 2004.
17. Rothstein, S.N., Federspiel, W.J., and Little, S.R. A simple model framework for the prediction of controlled release from bulk eroding polymer matrices. J Mater Chem 18, 1873, 2008.
18. Rothstein, S.N., Federspiel, W.J., and Little, S.R. A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matrices. Biomaterials 30, 1657, 2009.
19. Tengood, J.E., Kovach, K.M., Vescovi, P.E., Russell, A.J., and Little, S.R. Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis. Biomaterials 31, 7805, 2010.
20. Hasegawa, M., Sudo, A., Komlev, V.S., Barinov, S.M., and Uchida, A. High release of antibiotic from a novel hydroxyapatite with bimodal pore size distribution. J Biomed Mater Res B Appl Biomater 70, 332, 2004.
21. Nunes, S.P., and Inoue, T. Evidence for spinodal decomposition and nucleation and growth mechanisms during membrane formation. J Membr Sci 111, 93, 1996.
22. Shih, C.H., Gryte, C.C., and Cheng, L.P. Morphology of membranes formed by the isothermal precipitation of polyamide solutions from water/formic acid systems. J Appl Polym Sci 96, 944, 2005.
23. van de Witte, P., Dijkstra, P.J., van den Berg, J.W.A., and Feijen, J. Phase separation processes in polymer solutions in relation to membrane formation. J Membr Sci 117, 1, 1996.
24. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19, 1029, 2001.
25. Lee, H.J., Lee, H.J., Song, G.Y., Li, G., Lee, J.H., Lu, J., and Kim, S.H. 6-(1-Oxobutyl)-5,8-dimethoxy-1,4-naphthoquinone inhibits lewis lung cancer by antiangiogenesis and apoptosis. Int J Cancer 120, 2481, 2007.
26. Wacker, B.K., Scott, E.A., Kaneda, M.M., Alford, S.K., and Elbert, D.L. Delivery of sphingosine 1-phosphate from poly(ethylene glycol) hydrogels. Biomacromolecules 7, 1335, 2006.
27. Wendler, C.C., and Rivkees, S.A. Sphingosine-1-phosphate inhibits cell migration and endothelial to mesenchymal cell transformation during cardiac development. Dev Biol 291, 264, 2006.
28. Okamoto, H., Takuwa, N., Yokomizo, T., Sugimoto, N., Sakurada, S., Shigematsu, H., and Takuwa, Y. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by theG protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol Cell Biol 20, 9247, 2000.
29. Borges, J., Müller, M.C., Momeni, A., Stark, G.B., and Torio- Padron, N. In vitro analysis of the interactions between preadipocytes and endothelial cells in a 3D fibrin matrix. Minim Invasive Ther Allied Technol 16, 141, 2007.
30. Magnusson, P.U., Looman, C., Ahgren, A., Wu, Y., Claesson- Welsh, L., and Heuchel RL. Platelet-derived growth factor receptor-{beta} constitutive activity promotes angiogenesis in vivo and in vitro. Arterioscler Thromb Vasc Biol 27, 2142, 2007.
31. Hughes, A.D., Clunn, G.F., Refson, J., and Demoliou-Mason, C. Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle. Gen Pharmacol 27, 1079, 1996.
32. Chegini, N., Rossi, M.J., and Masterson, B.J. Platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and EGF and PDGF beta-receptors in human endometrial tissue: localization and in vitro action. Endocrinology 130, 2373, 1992.
33. Baudelet, C., Cron, G.O., Ansiaux, R., Crokart, N., DeWever, J., Feron, O., and Gallez, B. The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2*-weighted GRE signal within tumors. NMR Biomed 19, 69, 2006.
34. Chen, R.R., Silva, E.A., Yuen, W.W., and Mooney, D.J. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 24, 258, 2007.
35. Peters, M.C., Polverini, P.J., and Mooney, D.J. Engineering vascular networks in porous polymer matrices. J Biomed Mater Res 60, 668, 2002.
36. Sun, Q., Chen, R.R., Shen, Y., Mooney, D.J., Rajagopalan, S., and Grossman, P.M. Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. Pharm Res 22, 1110, 2005.
37. Kerbel, R., and Folkman, J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2, 727, 2002.
38. Bergers, G., Javaherian, K., Lo, K.M., Folkman, J., and Hanahan, D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808, 1999.
39. Whitney, J.A., German, Z., Sherman, T.S., Yuhanna, I.S. and Shaul, P.W. Cell growth modulates nitric oxide synthase expression in fetal pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 278, L131, 2000.
40. Igarashi, J., and Michel, T. S1P and eNOS regulation. Biochim Biophys Acta 1781, 489, 2008.
41. Patel, Z.S., Young, S., Tabata, Y., Jansen, J.A., Wong, M.E., and Mikos, A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
42. Yamamoto, M., Ikada, Y., and Tabata, Y. Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed 12, 77, 2001.
43. Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J., and Rees, D.C. Heparin structure and interactions with basic fi- broblast growth factor. Science 271, 1116, 1996.
44. Pellegrini, L., Burke, D.F., von Delft, F., Mulloy, B., and Blundell, T.L. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407, 1029, 2000.
45. Pellegrini, L. Role of heparan sulfate in fibroblast growth factor signalling: a structural view. Curr Opin Struct Biol 11, 629, 2001.
46. Gosain, A., Matthies, A.M., Dovi, J.V., Barbul, A., Gamelli, R.L., and DiPietro, L.A. Exogenous pro-angiogenic stimuli cannot prevent physiologic vessel regression. J Surg Res 135, 218, 2006.
47. Matthies, A.M., Low, Q.E., Lingen, M.W., and DiPietro, L.A. Neuropilin-1 participates in wound angiogenesis. Am J Pathol 160, 289, 2002.
48. Dang, D.T., Chun, S.Y., Burkitt, K., Abe, M., Chen, S., Havre, P., Mabjeesh, N.J., Heath, E.I., Vogelzang, N.J., Cruz-Correa, M., Blayney, D.W., Ensminger, W.D., St Croix, B., Dang, N.H., and Dang, L.H. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition. Cancer Res 68, 1872, 2008.
49. Heldin, C.H., and Westermark, B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79, 1283, 1999.
50. Schollmann, C., Grugel, R., Tatje, D., Hoppe, J., Folkman, J., Marme, D., and Weich, H. A. Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isoforms by specific upregulation of the PDGF alpha receptor in vascular smooth muscle cells. J Biol Chem 267, 18032, 1992.
51. Darland, D.C., and D'Amore, P. A. Blood vessel maturation: vascular development comes of age. J Clin Invest 103, 157, 1999.
52. Papanas, N., and Maltezos, E. Becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Clin Interv Aging 3, 233, 2008.
53. Bauer, S.M., Bauer, R.J., and Velazquez, O.C. Angiogenesis, vasculogenesis, and induction of healing in chronic wounds. Vasc Endovasc Surg 39, 293, 2005.
54. Giordano, F.J., and Johnson, R.S. Angiogenesis: the role of the microenvironment in flipping the switch. Curr Opin Genet Dev 11, 35, 2001.
55. Hansen-Smith, F.M. Capillary network patterning during angiogenesis. Clin Exp Pharmacol Physiol 27, 830, 2000.
56. Sampath, T.K., Maliakal, J.C., Hauschka, P.V., Jones, W.K., Sasak, H., Tucker, R.F., White, K.H., Coughlin, J.E., Tucker, M.M., Pang, R.H., et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267, 20352, 1992.
57. Wang, E.A., Rosen, V., D'Alessandro, J.S., Bauduy, M., Cordes, P., Harada, T., Israel, D.I., Hewick, R.M., Kerns, K.M., LaPan, P., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87, 2220, 1990.
58. Wozney, J.M. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32, 160, 1992.
59. Cheng, H., Jiang, W., Phillips, F.M., Haydon, R.C., Peng, Y., Zhou, L., Luu, H.H., An, N., Breyer, B., Vanichakarn, P., Szatkowski, J.P., Park, J.Y., and He, T.C. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85A, 1544, 2003